ARCHIVES

Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials

This article is from The Cancer Letter archive.

Vol. 04 No. 36 | September 8, 1978

Download PDF Visit The Full Archive

Related Articles

PRI Purchased By DynCorp; NCI Is Assured No Changes Will Be Made At Frederick

April 13, 1990

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006

Oxandrolone And Education Improves Weight Gain

February 28, 2003

In Brief: Daniel Ihde Named NCI Deputy Director; Roper Is Carter consultant; Another Honor For Forei

February 8, 1991

NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding

May 6, 1994